
Solid Biosciences Inc (SLDB)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -35.772 | -67.307 | -69.325 | -96.453 | -64.295 | -35.777 | -34.907 | -45.163 |
Return on Equity (%) | 59.608 | 80.947 | -226.915 | -114.235 | -83.24 | -42.426 | -40.955 | -56.789 |
Return on Invested Capital (%) | 88.158 | 109.211 | -239.732 | -115.983 | -83.276 | -42.701 | -50.97 | -61.864 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | -530.015 | -1062.281 | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | -530.015 | -1062.281 | N/A |
Book Value Per Share | -7.394 | -1.524 | 1.685 | 0.943 | 1.067 | 1.395 | 3.622 | 2.142 |
Earnings Per Share | -3.363 | -1.011 | -1.007 | -1.381 | -0.713 | -0.484 | -1.471 | -1.626 |
Cash Per Share | 1.498 | 1.34 | 1.162 | 0.896 | 1.25 | 0.798 | 2.659 | 1.253 |
Working Capital Per Share | 6.46 | 1.528 | 1.563 | 0.802 | 1.086 | 1.334 | 3.374 | 1.951 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | 0.091 | 0.139 | N/A |
EBIT Per Share | -4.64 | -1.368 | -1.007 | -1.381 | -0.713 | -0.484 | -1.471 | -1.626 |
EBITDA Per Share | -4.64 | -1.368 | -1.007 | -1.381 | -0.713 | -0.484 | -1.471 | -1.626 |
Free Cash Flow Per Share | -3.297 | -0.964 | -0.923 | -1.363 | -0.738 | -0.495 | -1.461 | -1.644 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | N/A | N/A | 35,43M | 45,99M | 84,89M | 110,34M | 19,56M | N/A |
Fin d'année 31 Décembre 2023 | Sept 2022 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 7,53M | 19,56M | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 219,75M |
Ratio cours/bénéfice | -2,26 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 2,93 |
Ratio prix/valeur comptable | 1,71 |
Rendement de dividende | - |
Actions en circulation | 39,95M |
Volume moyen (1 semaine) | 1,1M |
Volume moyen (1 mois) | 5,56M |
Variation sur 52 semaines | -42,28% |
Plus haut sur 52 semaines | 15,05 |
Plus bas sur 52 semaines | 2,88 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales